Toxicity of concurrent chemoradiotherapy and consolidation chemotherapy with docetaxel and cisplatin in stage Ⅲ non-small cell lung cancer:a phase Ⅰ trial
( views:348, downloads:28 )
Author:
No author available
Journal Title:
CHINESE JOURNAL OF RADIATION ONCOLOGY
Issue:
5
DOI:
10.3760/cma.j.issn.1004-4221.2009.05.362
Key Word:
癌;非小细胞肺/放射疗法;癌;非小细胞肺/化学疗法;综合疗法;Ⅰ期临床试验;Neoplasm;non-small cell lung/radiotherapy;Neoplasm;non-small cell lung/chem-otherapy;Combined modality therapy;Clinical trial of Phase Ⅰ
[1]王卫华,包勇,陈明,等.诱导化疗和紫杉醇每周同期化疗结合三维适形放射治疗不能手术的Ⅲ期非小细胞肺癌的初步结果 [J].2006,(10).
[2]包勇,陈明,王卫华,等.CT横断面上肺癌淋巴引流区域的界定及勾画 [J].2006,(6).
[3]Skarlatos J,Christodoulou M,Kyrias G,etc.Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma. [J].1999,80(11).
[4]Jett J,Chansky K,Albain KS,etc.Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023. [J].2008,26(15).
[5]Kim Y,Berille J,Ramlau R,etc.Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. [J].2000,18(10).
[6]Nishikawa H,Takada Y,Kudoh S,etc.Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. [J].1999,17(9).
[7]Albain KS,Beasley KR,Farrar WB,etc.Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019. [J].2002,20(16).
[8]Harrington D,Johnson DH,Belani CP,etc.Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. [J].2002,346(2).
[9]Brunsvig PF,Berg R,Hatlevoll R,etc.Weekly docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer: a phase I/II study with 5 years' follow-up. [J].2005,50(1).